First human test of new depression pill checks safety
NCT ID NCT04981561
Summary
This early-stage study aimed to check the safety and tolerability of a new oral drug called AGN-241751 (zelquistinel) in healthy people. Researchers gave 68 healthy volunteers single, increasing doses of the drug or a placebo to see how their bodies reacted and processed it. The main goal was to gather initial safety data and understand how the drug moves through the body, not to treat depression.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.